1 in every 6 adults will have depression at some point in their life, affecting nearly 16 million Americans every year. That's according to the CDC. But a new business in Winona is offering alternative ways to beat these statistics.
The US Food and Drug Administration approved Janssen Pharmaceuticals Inc.'s esketamine on Tuesday for treatment-resistant depression; the drug is the chemical cousin of ketamine, the powerful anesthetic that has been used illegally as the club drug Special K.
A ketamine-like drug for treatment-resistant depression was backed by a US Food and Drug Administration advisory committee on Tuesday. If it is then approved by the FDA, the drug -- called esketamine -- may provide a new option for patients with major depressive disorder who have tried at least two other antidepressants without success.
The Minneapolis Office of Police Conduct Review says it found eight cases in the past two years where officers were involved in deciding whether paramedics should sedate citizens.
A consumer rights group has filed a complaint alleging a Minneapolis health care provider ignored ethical practices and federal safeguards when it researched the effect of the powerful sedative ketamine on more than 100 participants without their prior consent.
A city report shows Minneapolis police officers have repeatedly requested that Hennepin County medical responders sedate people with ketamine, a tranquilizer known as the "date rape drug."
